Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2000
11/16/2000WO2000026370A3 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/16/2000WO2000026247A3 Ikaros isoforms and mutants
11/16/2000WO2000026241A3 Novel compositions and methods of screening for t-cell and b-cell activation modulators
11/16/2000WO2000023621A3 Visualization of rna in living cells
11/16/2000WO2000023466A3 Human rna binding proteins
11/16/2000WO2000023464A3 Zinc finger binding domains for gnn
11/16/2000WO2000022439A3 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections
11/16/2000WO2000020556A3 Zinc finger-reactive antimicrobial compounds
11/16/2000WO2000020448A3 Nlk1 -interacting proteins
11/16/2000WO2000018916A3 Human genes and gene expression products
11/16/2000WO2000009549A3 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
11/16/2000WO2000005375A9 Gbs toxin receptor
11/16/2000WO2000000158A3 Alkylamines and their precursors as specific modulators of human gamma-delta t cell function
11/16/2000WO1999051186A3 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
11/16/2000DE19936875A1 Verfahren zum Nachweisen von Mikroorganismen in einer Probe A method of detecting microorganisms in a sample
11/16/2000DE19922052A1 Determining the effect of chemotherapy and/or radiotherapy on malignancies comprises determining the expression profiles of or mutations in genes that regulate apoptosis and/or cell growth
11/16/2000DE19921999A1 Continuous determination of concentration of organisms suspended in liquid is achieved by inference from a variation in parameters of one or more metabolites, using data acquisition system
11/16/2000DE19921419A1 Verfahren zum spezifischen Nachweis und zur Identifizierung retroviraler Nukleinsäuren / Retroviren in einem Untersuchungsgut A method for specific detection and identification of retroviral nucleic acids / retrovirus in a specimen material
11/16/2000DE19920514A1 Methoden zur Auffindung von Proteasen, die spezifisch membrangebundene Substrate spalten Methods for the detection of proteases that cleave specific membrane-bound substrates
11/16/2000DE19920244A1 Determining the inhibiting effect of a waste water sample on microbial nitrification, using a preserved pure culture of a nitrifying bacterial strain as test organism
11/16/2000DE10012670A1 Isolation of metaphase chromosomal material comprises chromosomal microdissection after hybridizing fluorescence-labeled DNA probes to the target material
11/16/2000CA2721199A1 Isolating biological modulators from biodiverse gene fragment libraries
11/16/2000CA2374237A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000CA2373759A1 Serine proteases
11/16/2000CA2373550A1 Methods of identifying therapeutic compounds in a genetically defined setting
11/16/2000CA2373182A1 A structure-based approach to design inhibitors of protein-processivity factor interactions
11/16/2000CA2373061A1 Diagnosis of primary congenital glaucoma
11/16/2000CA2373044A1 Nucleic acid sequencing with simultaneous quantitation
11/16/2000CA2372993A1 Diagnosis of glaucoma
11/16/2000CA2372968A1 Whole cell assay for cathepsin k
11/16/2000CA2372854A1 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery
11/16/2000CA2372837A1 Cytokine receptor mouse zcytor10
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
11/16/2000CA2372735A1 Assay reagent
11/16/2000CA2372699A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000CA2372597A1 Human gabab receptor 1 promoters
11/16/2000CA2371843A1 Multiple tag analysis
11/16/2000CA2371195A1 Cells and assays
11/16/2000CA2370212A1 Methods of discovering proteases which specifically cleave membrane-bound substrates
11/16/2000CA2369577A1 Method for detecting microorganisms in a sample
11/16/2000CA2368315A1 Apparatus and process for monitoring and detecting small molecule-biomolecule interactions
11/16/2000CA2337007A1 Sample evaporative control
11/16/2000CA2336956A1 Dehydrated immediate reconstruction culture medium to identify group b streptococci streptococcus agalactiae by the detection of their pigment
11/15/2000EP1052511A1 Method for testing crohn's disease and testing kit therefor
11/15/2000EP1052293A1 Nucleic acid detection in cytoplasm
11/15/2000EP1052292A1 Prostate cancer gene
11/15/2000EP1052291A2 Fluorescent stain containing pyrylium salt or its similar salt, detection method of nucleic acid by use of it
11/15/2000EP1051625A1 Assessing risk for integrin antagonist/agonist mediated diseases
11/15/2000EP1051622A1 PAI-2 AND t-PA AS DIAGNOSTIC MARKERS OF PERIODONTAL DISEASE
11/15/2000EP1051523A2 Nucleic acid analysis method
11/15/2000EP1051522A2 Method for quantitatively analyzing tumor cells in a body fluid and test kits suited therefor
11/15/2000EP1051521A2 Method of screening therapeutic agents
11/15/2000EP1051520A1 Improved method for the isolation of nucleic acid
11/15/2000EP1051519A2 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
11/15/2000EP1051517A2 Amplification of nucleic acids with electronic detection
11/15/2000EP1051516A1 Gene expression methods for screening compounds
11/15/2000EP1051515A2 Modified nucleic acid probes and uses thereof
11/15/2000EP1051514A1 Method of isolation of rna-binding compounds
11/15/2000EP1051513A1 Polymeric arrays and methods for their use in binding assays
11/15/2000EP1051512A1 Method for detecting and identifying mutations
11/15/2000EP1051511A1 Methods of identifying modulators of kinases responsive to stress
11/15/2000EP1051510A1 A rapid method for the assessment of the inhibition and kill of anaerobic bacteria by toxic compounds
11/15/2000EP1051509A1 Use of indolamine derivatives for detecting micro-organism peptidase
11/15/2000EP1051508A1 Pancreatic eukaryotic translation initiation factor-2alpha kinase
11/15/2000EP1051507A1 Antigen-specific cells, methods of generating these cells and uses thereof
11/15/2000EP1051504A2 Riboflavin biosynthesis genes from plants and uses thereof
11/15/2000EP1051500A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/15/2000EP1051497A2 Human protein kinase molecules
11/15/2000EP1051490A2 Modulation of cell proliferation, methods and reagents
11/15/2000EP1051489A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
11/15/2000EP1051488A2 Human growth factor homologs
11/15/2000EP1051487A1 Placental protein 13
11/15/2000EP1051486A1 Gtpase derived from human lymph nodes that effects the morphology and cytoskeleton organization of endothelial cells
11/15/2000EP1051485A1 Trek-1 like two pore potassium channel
11/15/2000EP1051484A1 Gene regulator fusion proteins and methods of using the same for determining resistance of a protein to a drug targeted there against
11/15/2000EP1051482A1 Cytotoxic heteromeric protein combinatorial libraries
11/15/2000EP1051481A1 Secreted proteins and polynucleotides encoding them
11/15/2000EP1051479A1 Novel steroid-activated nuclear receptors and uses therefor
11/15/2000EP1051430A2 Array fabrication methods
11/15/2000EP1051429A1 Ldl related protein and uses thereof
11/15/2000EP1051428A1 Human cystatin f
11/15/2000EP1051427A1 Spoil protein and nucleic acid molecules and uses therefor
11/15/2000EP0828826A4 Plant promoter activated by fungal infection
11/15/2000EP0808374A4 Method for modulating processes mediated by farnesoid activated receptors
11/15/2000EP0771359A4 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors
11/15/2000EP0601129B1 Morphogenic protein screening method
11/15/2000EP0592423B1 Methods for the identification of cytokine convertase inhibitors
11/15/2000CN1273609A Method and compositions for detection or quantification of nucleic acid species
11/15/2000CN1273363A Method for detecting false positive and false negative cross signals of DNA chip
11/15/2000CN1273362A Process for preparing middle-density DNA (gene) chip
11/15/2000CN1058524C Heat tolerant phytases
11/14/2000US6147279 Inhibition of gene expression
11/14/2000US6147277 Nucleotide sequences which encode an enzymatic protein associate with hydrolysis of starch; for use during horticulture and preferential plant selection
11/14/2000US6147204 Complex for targeting therapeutic or diagnostic agents to preferential biological target
11/14/2000US6147199 Viricides
11/14/2000US6147198 Methods and compositions for the manipulation and characterization of individual nucleic acid molecules
11/14/2000US6147192 Proteins associated with weight control; for the treatmen of eating disorders
11/14/2000US6147190 Protein associated with activating cell propagation; for the treatment of a nervous system disorders; for diagnosis and treatment of tumors; antitumor agents
11/14/2000US6147050 5-lipoxygenase-activating protein II
11/14/2000US6146896 Evaluating nitrogen fixation efficiency of sewage; supplying sewage, nitrifying bacteria, aqueous solution, oxygen, and a suppressor to vessel, allow oxygen consumption, measure oxygen by comparison between separate vessels
1 ... 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 ... 3003